• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

    81.30 +0.71 (+0.88%)
    Streaming Delayed Price Updated: 1:29 PM EDT, Apr 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Lantheus Holdings, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    22 23 Next >
    News headline image
    3 Profitable Stocks We Think Twice About
    Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
    Via StockStory
    News headline image
    3 Cash-Producing Stocks Walking a Fine Line
    Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
    Via StockStory
    News headline image
    1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore
    Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
    Via StockStory
    News headline image
    3 Russell 2000 Stocks We’re Skeptical Of
    Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
    Via StockStory
    Lantheus Holdings Inc (NASDAQ:LNTH) Beats Q4 Estimates but 2026 Guidance Disappoints ↗
    Via Chartmill
    Lantheus Holdings Inc. (NASDAQ:LNTH) Presents a Compelling Value Investment Case ↗
    Via Chartmill
    Lantheus Holdings Inc (NASDAQ:LNTH) Presents a Compelling Value Case with Strong Fundamentals ↗
    Via Chartmill
    News headline image
    Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application ↗
    The agency is now slated to decide on the company’s application seeking approval for the diagnostic kit by June 29. 
    Via Stocktwits
    News headline image
    Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    News headline image
    3 Reasons to Sell LNTH and 1 Stock to Buy Instead
    What a fantastic six months it’s been for Lantheus. Shares of the company have skyrocketed 57%, hitting $83.14. This run-up might have investors contemplatin... 
    Via StockStory
    Topics Supply Chain
    News headline image
    Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
    Let’s dig into the relative performance of Lantheus (NASDAQ:LNTH) and its peers as we unravel the now-completed Q4 medical devices & supplies - imaging, diag... 
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Why Lantheus Holdings Stock Popped by Almost 12% Last Month ↗
    Investors were clearly impressed by the medical device specialist's fourth-quarter performance. 
    Via The Motley Fool
    News headline image
    Why Is LNTH Stock Up After Hours? ↗
    Lantheus said that the FDA approved its PYLARIFY TruVu injection. 
    Via Stocktwits
    News headline image
    Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Lantheus (LNTH) Q4 2025 Earnings Call Transcript ↗
    Lantheus (LNTH) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations
    Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 4% year on year to $406.8 million. On the other hand, the company’s... 
    Via StockStory
    News headline image
    Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    News headline image
    Lantheus Earnings: What To Look For From LNTH
    Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings this Thursday before the bell. Here’s what to expect. 
    Via StockStory
    Topics Economy World Trade
    News headline image
    Lantheus to Present at March 2026 Investor Conferences
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    News headline image
    2 Value Stocks to Target This Week and 1 Facing Headwinds
    The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
    Via StockStory
    News headline image
    Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    News headline image
    2 Small-Cap Stocks Worth Investigating and 1 We Avoid
    Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
    Via StockStory
    News headline image
    Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
    From Kahn Swick & Foti, LLC
    Via Business Wire
    News headline image
    3 Market-Beating Stocks for Long-Term Investors
    The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
    Via StockStory
    News headline image
    Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    News headline image
    2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
    Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, which has supported the... 
    Via StockStory
    Topics Stocks
    News headline image
    Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year ↗
    The move suggests that shrinking margins, leadership turnover, and a shifting product mix are quietly reshaping the Lantheus investment case. 
    Via The Motley Fool
    Topics Regulatory Compliance Supply Chain
    News headline image
    This Healthcare Stock Still Commands a Top 3 Portfolio Slot Despite a Steep Slide This Past Year ↗
    After a bruising year for the stock, one fund leaned further into a business throwing off real cash and quietly reshaping its growth engine. 
    Via The Motley Fool
    Topics Regulatory Compliance
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    22 23 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.